Thursday, December 3, 2020

Food and Beverage

Emerging Growth Food and Beverage Companies

M&A in Healthcare sparked by Covid-19

Johnson & Johnson (NYSE: JNJ) agreed to buy Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) for about $6.5 billion to expand in treatments for autoimmune diseases. And Sanofi (NASDAQ: SNY) said it would buy biotech company Principia Biopharma Inc., which develops treatments for multiple sclerosis and a range of autoimmune disorders, for $3.4 billion, as the French drug maker pivots toward innovative therapies to spur growth.”

Biotech Debt is Through the Roof; Where to find value

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

If you could only own 3 stocks, what would they be?

Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) and cite that it’s like owning the greatest fund out there, but with one exception… It has the best manager. Warren Buffett just turned 90 years old, BRK is down 8% YTD, and we all remember what happened when Steve Jobs passed. There will be a better opportunity to own BRK sometime in the future.

The Top Diabetes Stocks for the remainder of 2020

Here is a company in the space that is finding its way onto the shelves of some major pharmacy retailers including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $30 million valuation.

Healthcare Stocks and the cost of Medical

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

The Covid-19 Vaccine is here, and the Winner Is

The goal in the US is to have a vaccine ready for at least some use by year end. Given the stringent approval process by the US FDA, it could be safe to say that another country may beat us to it. China and Russia have both made claims to this effect. But how safe will they be? Will there be any lasting side effects?

Food and Beverage Stocks in the Covid-19 Era

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Stocks to be in before 2021

Glucose Health, Inc. is an under-the-radar company whose GLUCODOWN® products are found in major national pharmacy chains including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and even online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $20 million valuation.

The Stocks to own after the Presidential Election

Joe Biden wants to put the U.S. on track to achieve "a 100% clean energy economy and Brookfield Renewable Partners (NYSE:BEP) stands out as one stock positioned to perform especially well as three-quarters of the company's funds from operations (FFO) comes from its hydroelectric facilities.

Epazz (EPAZ) DeskFlex Room Booking Software Is Receiving Increased Demand From Universities and Colleges...

Epazz DeskFlex Room Booking Software Is Receiving Increased Demand From Universities and Colleges Struggling to Reopen After COVID-19 Lockdowns DeskFlex Course Scheduling Software for universities receives more requests from schools, colleges and universities to reopen safely amidst the coronavirus pandemic.

Latest News